Risk Profile in Chronic Kidney Disease Stage 3: Older versus Younger Patients

被引:22
|
作者
McIntyre, Natasha J. [1 ]
Fluck, Richard J. [1 ]
McIntyre, Christopher W. [1 ,2 ]
Taal, Maarten W. [1 ]
机构
[1] Royal Derby Hosp, Dept Renal Med, Derby DE22 3NE, England
[2] Univ Nottingham, Dept Vasc Med, Nottingham NG7 2RD, England
来源
NEPHRON CLINICAL PRACTICE | 2011年 / 119卷 / 04期
关键词
Cardiovascular disease; Chronic kidney disease; Epidemiology; Older patients; Risk factors; GLOMERULAR-FILTRATION-RATE; PULSE-WAVE VELOCITY; RENAL-DISEASE; CARDIOVASCULAR EVENTS; ARTERIAL STIFFNESS; URIC-ACID; ALL-CAUSE; MORTALITY; METAANALYSIS; PREVALENCE;
D O I
10.1159/000329109
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The prevalence of chronic kidney disease (CKD) increases with age, but its significance in older patients is uncertain and is regarded by some as part of 'normal aging'. Moreover, subjects >= 75 years are often excluded from research studies. We therefore undertook a prospective study of patients with CKD stage 3 in primary care to compare the risk profile of older versus younger subjects. Methods: Subjects with an estimated glomerular filtration rate (eGFR) 59-30 ml/min/1.73 m(2) on two measurements were recruited from 32 primary care practices. Medical history and demographic data were obtained and participants underwent clinical assessment as well as urine and serum biochemistry tests. Results: 1,741 participants were recruited: mean age 72.9 +/- 8 9 years; 60% female; 98% white; 17% diabetic. Mean eGFR was 52.5 +/- 8 10 ml/min/1.73 m(2) and 16.9% had albuminuria. Subjects >= 75 years had a significantly lower eGFR than younger subjects and a higher risk profile characterised by greater albuminuria, more arterial stiffness and higher serum uric acid levels. Conclusion: Older subjects with CKD stage 3 evidenced a higher risk profile for CKD progression and cardiovascular events than younger patients. This implies that CKD is not a benign condition in all elderly patients, but further investigation is required to identify those at greatest risk who may benefit from intervention. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:C269 / C276
页数:8
相关论文
共 50 条
  • [21] Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5
    Lu, Jing-Wun
    Chi, Po-Jui
    Lin, Yu-Li
    Wang, Chih-Hsien
    Hsu, Bang-Gee
    ADIPOCYTE, 2020, 9 (01) : 206 - 211
  • [22] Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3-5 chronic kidney disease
    Hu, Yue
    Wang, Xiaotong
    Xiao, Shengjue
    Wu, Huimin
    Huan, Chunyan
    Xu, Tao
    Guo, Minjia
    Liu, Ailin
    Jiang, Xiaoyao
    Wang, Jia
    Zhu, Hong
    Pan, Defeng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (05) : 1353 - 1363
  • [23] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Lorien S. Dalrymple
    Ronit Katz
    Bryan Kestenbaum
    Michael G. Shlipak
    Mark J. Sarnak
    Catherine Stehman-Breen
    Stephen Seliger
    David Siscovick
    Anne B. Newman
    Linda Fried
    Journal of General Internal Medicine, 2011, 26 : 379 - 385
  • [24] Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study
    Eveleens Maarse, Boukje C.
    Chesnaye, Nicholas C.
    Schouten, Robbert
    Michels, Wieneke M.
    Bos, Willem Jan W.
    Szymczak, Maciej
    Krajewska, Magdalena
    Evans, Marie
    Heimburger, Olof
    Caskey, Fergus J.
    Wanner, Christoph
    Jager, Kitty J.
    Dekker, Friedo W.
    Meuleman, Yvette
    CLINICAL KIDNEY JOURNAL, 2022, 15 (04) : 786 - 797
  • [25] Smoking habit as a risk amplifier in chronic kidney disease patients
    Provenzano, Michele
    Serra, Raffaele
    Michael, Ashour
    Bolignano, Davide
    Coppolino, Giuseppe
    Ielapi, Nicola
    Serraino, Giuseppe Filiberto
    Mastroroberto, Pasquale
    Locatelli, Francesco
    De Nicola, Luca
    Andreucci, Michele
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] Risk of chronic kidney disease in patients with obstructive sleep apnea
    Beaudin, Andrew E.
    Raneri, Jill K.
    Ahmed, Sofia B.
    Allen, A. J. Marcus Hirsch
    Nocon, Andrhea
    Gomes, Teresa
    Gakwaya, Simon
    Series, Frederic
    Kimoff, John
    Skomro, Robert P.
    Ayas, Najib T.
    Hanly, Patrick J.
    SLEEP, 2022, 45 (02)
  • [27] Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)
    Yuan, Jun
    Zou, Xin-Rong
    Han, Si-Ping
    Cheng, Hong
    Wang, Lan
    Wang, Jin-Wei
    Zhang, Lu-Xia
    Zhao, Ming-Hui
    Wang, Xiao-Qin
    BMC NEPHROLOGY, 2017, 18
  • [28] Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
    Fraser, Simon D. S.
    Roderick, Paul J.
    McIntyre, Natasha J.
    Harris, Scott
    McIntyre, Christopher
    Fluck, Richard
    Taal, Maarten W.
    PLOS ONE, 2014, 9 (05):
  • [29] Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine
    Carlos Bureo, Juan
    Carlos Arevalo, Jose
    Anton, Joaquin
    Adrados, Gaspar
    Jimenez Morales, Jose Luis
    Roberto Robles, Nicolas
    ENDOCRINOLOGIA Y NUTRICION, 2015, 62 (07): : 300 - 305
  • [30] The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
    Portoles, Jose
    Luis Gorriz, Jose
    Rubio, Esther
    de Alvaro, Fernando
    Garcia, Florencio
    Alvarez-Chivas, Vicente
    Aranda, Pedro
    Martinez-Castelao, Alberto
    BMC NEPHROLOGY, 2013, 14